ClinicalTrials.gg
Not yet recruitingNCT07541963Updated Nov 17, 2026

Investigation of the Effect of Screen Time Before Sleep on Posture Disorders and Dynamic Balance

An observational study in Postural Disorders and Balance Problems, sponsored by Saglik Bilimleri Universitesi. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Saglik Bilimleri Universitesi · Observational

How we know

Updated Nov 17, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
34
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The widespread use of electronic devices such as smartphones, tablets, and laptops has significantly increased screen exposure, especially before sleep. Prolonged screen use may contribute to poor posture by promoting forward head posture, rounded shoulders, and other musculoskeletal problems. In addition, screen exposure before sleep may negatively affect sleep quality and neuromuscular performance, which may in turn influence postural control and balance.

Read the detailed description

Postural disorders arise from the disruption of the natural alignment of the spine and are often associated with muscle imbalances, joint stress, and pain. Incorrect posture caused by prolonged technology use has been reported to increase the risk of musculoskeletal problems among young adults.

Dynamic balance is an important component of postural control and is influenced by the integration of sensory input and neuromuscular responses. Sleep disturbances and lifestyle habits, including excessive screen exposure before sleep, may affect this complex system.

Therefore, the aim of this study is to investigate the effect of screen time before sleep on posture disorders and dynamic balance in healthy young adults. Participants aged between 18 and 35 years will be evaluated for screen usage habits before sleep. Posture analysis and the Star Excursion Balance Test will be used to assess posture alignment and dynamic balance performance.

02

Conditions studied

  • Postural Disorders
  • Balance Problems
03

In context

Lead sponsor

Saglik Bilimleri Universitesi is the lead sponsor of 458 studies on the registry; 124 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

34 healthy volunteers between the ages of 18-35 were included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults
  • Aged 18 to 35 years
  • Willing to participate voluntarily in the study

Exclusion criteria

Exclusion Criteria:

  • History of orthopedic injury or surgery affecting balance
  • Use of medications that may affect attention or balance
  • Refusal to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
34 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy young individuals with pre-sleep screen exposure

    34 healthy volunteers between the ages of 18-35 were included in the study. Participants are assessed for screen exposure before sleep, posture disorders, and dynamic balance.

    Other: Pre-sleep screen exposure assessment

Interventions

  • OtherPre-sleep screen exposure assessment

    Pre-sleep screen exposure is evaluated using smartphone-based self-reported queries on duration and usage characteristics

06

What researchers measure

Primary outcomes

  1. Posture Analysis

    Evaluation of body alignment including head position, shoulder alignment, spinal curvature, pelvic position, knee alignment, and foot posture from anterior, posterior, and lateral views.

    Time frame: Single assessment at baseline

Secondary outcomes

  1. Star Excursion Balance Test

    Dynamic balance performance will be assessed by measuring the maximum reach distance in eight directions while maintaining single-leg stance.

    Time frame: Single assessment at baseline

  2. Duration of pre-sleep screen exposure

    The duration of screen exposure within 1 hour before bedtime will be assessed using self-report and recorded in minutes. Higher values indicate longer screen exposure before sleep.

    Time frame: Single assessment at baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Nov 2026; primary completion for May 2027, 5 months later.

Start moved once since we started tracking on Sep 25, 2026: May 2026 → Nov 2026, on Nov 17, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2026
First posted
Apr 21, 2026
StartEst.
Nov 30, 2026was May 2026
Primary completionEst.
May 1, 2027
CompletionEst.
May 1, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
May 1, 2026→Nov 30, 2026
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Start date May 1, 2026→Nov 30, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07541963
Responsible party
ESRA PEHLIVAN (Principal Investigator, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Apr 21, 2026
Start date
Nov 30, 2026 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Esra Pehlivan
Contact
esra.pehlivan@sbu.edu.tr
0 216 777 8 777
Rumeysa Yanak
Contact
rumeysayanakk@gmail.com
02167779600

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion